NDC Package Code : 53296-0018
Start Marketing Date : 2010-03-17
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (75kg/75kg)
Marketing Category : BULK INGREDIENT
55
PharmaCompass offers a list of Amoxapine API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Amoxapine manufacturer or Amoxapine supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Amoxapine manufacturer or Amoxapine supplier.
PharmaCompass also assists you with knowing the Amoxapine API Price utilized in the formulation of products. Amoxapine API Price is not always fixed or binding as the Amoxapine Price is obtained through a variety of data sources. The Amoxapine Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Amoxan manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Amoxan, including repackagers and relabelers. The FDA regulates Amoxan manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Amoxan API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Amoxan manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Amoxan supplier is an individual or a company that provides Amoxan active pharmaceutical ingredient (API) or Amoxan finished formulations upon request. The Amoxan suppliers may include Amoxan API manufacturers, exporters, distributors and traders.
click here to find a list of Amoxan suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Amoxan as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Amoxan API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Amoxan as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Amoxan and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Amoxan NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Amoxan suppliers with NDC on PharmaCompass.
